Outcomes of patients with small and node-negative HER2-positive early breast cancer treated with adjuvant chemotherapy and anti-HER2 therapy—a sub-analysis of the ALTTO study
Nader-Marta, Guilherme, Debien, Véronique, Eiger, Daniel, Tsourti, Zoi, Caparica, Rafael, Kassapian, Marie, Napoleone, Sylvia, Hultsch, Susanne, Korde, Larissa, Wang, Yingbo, Chumsri, Saranya, Pritchard, Kathleen I, Untch, Michael, Bellet-Ezquerra, Meritxell, Dornelles Rosa, Daniela, Moreno-Aspitia, Alvaro, Piccart, Martine, Dafni, Urania, de Azambuja, Evandro
Published in British journal of cancer (09.11.2022)
Published in British journal of cancer (09.11.2022)
Get full text
Journal Article
Effect of mevalonate pathway inhibitors on outcomes of patients (pts) with HER2-positive early breast cancer (BC) in the ALTTO trial
De Angelis, Carmine, Veeraraghavan, Jamunarani, Sethunath, Vidyalakshmi, Ameye, Lieveke, Paesmans, Marianne, El-Abed, Sarra, Choudhury, Anup, Napoleone, Sylvia, Chumsri, Saranya, Piccart-Gebhart, Martine J., Moreno-Aspitia, Alvaro, Gomez, Henry Leonidas, Viale, Giuseppe, Hilsenbeck, Susan G., Rimawi, Mothaffar F., Osborne, C. Kent, de Azambuja, Evandro, Schiff, Rachel
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article